1. Home
  2. CUBE vs KRYS Comparison

CUBE vs KRYS Comparison

Compare CUBE & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CubeSmart

CUBE

CubeSmart

HOLD

Current Price

$40.86

Market Cap

9.4B

Sector

Real Estate

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$358.57

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUBE
KRYS
Founded
2004
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4B
9.6B
IPO Year
2004
2017

Fundamental Metrics

Financial Performance
Metric
CUBE
KRYS
Price
$40.86
$358.57
Analyst Decision
Buy
Strong Buy
Analyst Count
15
11
Target Price
$44.00
$297.60
AVG Volume (30 Days)
2.0M
286.9K
Earning Date
04-30-2026
05-04-2026
Dividend Yield
5.34%
N/A
EPS Growth
N/A
128.00
EPS
0.36
3.62
Revenue
$1,123,110,000.00
$389,130,000.00
Revenue This Year
$0.66
$38.74
Revenue Next Year
$2.82
$32.53
P/E Ratio
$112.86
$98.40
Revenue Growth
5.33
33.94
52 Week Low
$35.09
$145.46
52 Week High
$43.26
$382.54

Technical Indicators

Market Signals
Indicator
CUBE
KRYS
Relative Strength Index (RSI) 44.69 57.92
Support Level $40.32 $253.89
Resistance Level $41.00 $382.33
Average True Range (ATR) 0.70 9.53
MACD -0.11 2.99
Stochastic Oscillator 17.70 93.51

Price Performance

Historical Comparison
CUBE
KRYS

About CUBE CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Majority of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: